Vitamin E analogues as inducers of apoptosis: structure-function relation
M Birringer1, J H EyTina, B A Salvatore
1German Institute of Human Nutrition, Potsdam-Rehbrücke, Germany.
Abstract:
Recent results show that alpha-tocopheryl succinate (alpha-TOS) is a proapoptotic agent with antineoplastic activity. As modifications of the vitamin E (VE) molecule may affect its apoptogenic activity, we tested a number of newly synthesised VE analogues using malignant cell lines. Analogues of alpha-TOS with lower number of methyl substitutions on the aromatic ring were less active than alpha-TOS. Replacement of the succinyl group with a maleyl group greatly enhanced the activity, while it was lower for the glutaryl esters. Methylation of the free succinyl carboxyl group on alpha-TOS and delta-TOS completely prevented the apoptogenic activity of the parent compounds. Both Trolox and its succinylated derivative were inactive. alpha-tocotrienol (alpha-T3 H) failed to induce apoptosis, while gamma-T3 H was apoptogenic, and more so when succinylated. Shortening the aliphatic side chain of gamma-T3 by one isoprenyl unit increased its activity. Neither phytyl nor oleyl succinate caused apoptosis. These findings show that modifications of different functional moieties of the VE molecule can enhance apoptogenic activity. It is hoped that these observations will lead to the synthesis of analogues with even higher apoptogenic and, consequently, antineoplastic efficacy.
Insights
Vitamin E (VE) analogues were synthesized and tested for their ability to induce apoptosis and fight cancer. Modifications to the VE molecule, particularly the succinyl group, significantly enhanced anti-cancer activity.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Alpha-tocopheryl succinate (alpha-TOS), a Vitamin E (VE) derivative, exhibits proapoptotic and antineoplastic properties.
- Modifications to the VE structure may influence its cancer-fighting capabilities.
Purpose of the Study:
- To investigate how structural modifications of VE analogues affect their apoptogenic and antineoplastic activities.
- To identify novel VE derivatives with enhanced efficacy against malignant cell lines.
Main Methods:
- Synthesis of novel VE analogues, including alpha-TOS derivatives with altered aromatic ring substitutions and ester groups.
- Testing the synthesized analogues on various malignant cell lines to assess their ability to induce apoptosis.
Main Results:
- Analogues with fewer methyl groups on the aromatic ring showed reduced activity compared to alpha-TOS.
- Replacing the succinyl group with maleyl significantly enhanced activity, while glutaryl esters were less potent.
- Methylation of the carboxyl group abolished apoptogenic activity.
- Alpha-tocotrienol (alpha-T3 H) was inactive, but gamma-tocotrienol (gamma-T3 H) was apoptogenic, especially when succinylated.
- Shortening the side chain of gamma-T3 H increased its activity.
Conclusions:
- Structural modifications of VE analogues, particularly the ester group and side chain, can significantly enhance apoptogenic and antineoplastic activity.
- These findings provide a basis for designing more potent VE-based anti-cancer agents.
More Related Videos
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Cellular Injury V: Apoptosis and Autophagy


